Management of Iron Deficiency and Persistent Bleeding in a 21-Year-Old with Contraceptive Implant
Start oral iron supplementation immediately with ferrous sulfate 200 mg once daily (or every other day if better tolerated), taken on an empty stomach with 500 mg vitamin C, and address the implant-associated bleeding separately through gynecological consultation. 1
Iron Deficiency Management
Your patient has clear iron deficiency with ferritin 11 ng/mL (below the 13 ng/mL threshold for women) and transferrin saturation 17.2% (below 20%), despite a currently normal hemoglobin of 135 g/L 2, 1. This represents iron deficiency without anemia that still requires treatment to prevent progression and restore iron stores.
Oral Iron Therapy - First Line
- Ferrous sulfate 200 mg once daily is the preferred initial treatment as the least expensive and equally effective option 1
- Take on an empty stomach for optimal absorption
- Add 500 mg vitamin C with each dose to enhance iron absorption 1
- Every-other-day dosing may be better tolerated with similar absorption rates due to hepcidin regulation, which blocks iron absorption for up to 48 hours after each dose 1, 2
- Expected hemoglobin rise: 2 g/dL after 3-4 weeks 3
Monitoring Response
Check hemoglobin and ferritin at 2-4 weeks to assess response 4, 5. Failure to show at least 10 g/L hemoglobin rise after 2 weeks predicts subsequent treatment failure (90% sensitivity) 4. If no response or intolerance develops, proceed to intravenous iron.
When to Use IV Iron
- Oral iron not tolerated (GI side effects occur in 12% constipation, 8% diarrhea, 11% nausea)
- Ferritin fails to improve after adequate oral trial
- Ongoing blood loss exceeds replacement capacity
- Malabsorption suspected
For IV iron, use single or two-dose formulations (ferric carboxymaltose, ferumoxytol, or iron isomaltoside) rather than multiple-dose preparations 1, 6. True anaphylaxis is very rare (<1:250,000) 2.
Treatment Duration
Continue iron for 3 months after hemoglobin normalizes to replenish iron stores 3, 7. Target ferritin >50 ng/mL in the absence of inflammation 6.
Bleeding Management - Separate Issue
The persistent bleeding since termination while on the contraceptive implant requires distinct management:
Key Considerations
- Implant-associated bleeding is common - up to 27% of users report bothersome bleeding 8
- Women with historically irregular menses (which may apply given the bleeding pattern) more often report problematic bleeding with implants 8
- Medical management of implant bleeding is associated with higher 1-year discontinuation rates (hazard ratio 1.98), though over 50% still continue use for 3 years 8
Practical Approach
- Refer to gynecology for bleeding pattern assessment and management options
- The bleeding itself contributes to ongoing iron loss, making iron replacement even more critical
- Management options for implant bleeding vary widely and lack strong evidence 9, but should be addressed by a specialist familiar with hormonal contraception
- Do not assume the bleeding is solely from the implant - in a 21-year-old with recent termination and persistent bleeding, ensure appropriate gynecological evaluation to exclude retained products of conception or other pathology
Common Pitfalls to Avoid
- Don't wait for anemia to develop - treat iron deficiency even with normal hemoglobin 1
- Don't take iron more than once daily - increased hepcidin blocks additional absorption and increases side effects 1
- Don't check ferritin within 4 weeks of IV iron - circulating iron interferes with the assay 6
- Don't ignore ongoing blood loss - iron replacement alone won't solve the problem if bleeding continues unaddressed
- Don't assume ferritin >20 ng/mL excludes iron deficiency in young women - recent evidence suggests thresholds of 24.8 μg/L may be more physiologically appropriate 10